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Abstract
GB virus C (GBV-C) is prevalent globally and particularly among individuals at risk of parental exposures. Based on genetic
diversity, this virus is now classified into six genotypes and many subtypes with distinct geographical distribution. In this
study, 120 Injecting Drug Users (IDUs) were recruited from Yunnan province, China. Among them, 43 (35.8%) were positive
for GBV-C RNA, 70 (58.3%) and 103 (85.8%) sero-positive for HIV-1 and HCV respectively. This revealed 18.3% of IDUs having
GBV-C/HIV/HCV triple infection, which is significantly higher than 7.5% of GBV-C/HIV-1 and 10% of GBV-C/HCV dual
infection rates (P,0.05). Based on 59UTR sequences, the identified 43 viral isolates can be classified into three phylogenetic
groups: one (2.3%) and two (4.7%) belonged to genotype 3 and 4, respectively, and the remaining 40 (93%) formed a new
group with 97% of bootstrap support. This new GBV-C group was further confirmed by characterizing the E2 region and full-
length genome sequences. Analysis of 187 nt 59UTR sequence showed three previous reported isolates from Southeast Asia
were re-classified into this new group. It implies they have the same origin with strains from Yunnan. Although we
provisionally assigned this new group as GBV-C genotype 7, a simpler five groups of GBV-C nomenclature is recommended.
Genotype 4, 6 and the newly designated genotype 7 could be reclassified as one group, which may represent a single GBV-
C genotype. The classification of the other four groups was corresponding to that of previous reported genotype 1, 2, 3 and
5. Furthermore, the diversity of amino acid sequence in the E2 region was analyzed. The inhibitory effect of GBV-C genotype
7 on HIV-1 cell entry could be deduced. Since GBV-C may have a beneficial effect on AIDS disease progression and interact
with HCV during co-infection, this finding may raise interests in future studies on this virus that was previously thought to
be a ‘‘non-pathogenic virus’’.
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Introduction
Discovered by two independent groups in the mid-1990s, GB
Virus C (GBV-C)/Hepatitis G Virus (HGV) has now been
classified as a member of the Flaviviridae family. GBV-C has a
single-stranded positive RNA genome of about 9.3 kb and
contains a single open reading frame (ORF) encoding two
structural (E1 and E2) and five non-structural (NS2, NS3, NS4,
NS5A, and NS5B) proteins [1,2]. Although with 25–30% of amino
acid sequence similarity to hepatitis C virus (HCV), the GBV-C
genome lacks the core region and hypervariable region of E2 gene.
In addition, its 39-untranslated region (UTR) displays a less
complex organization [3].
GBV-C infection has been found worldwide. High prevalence is
observed among subjects with the risk of parenteral exposures.
The subjects include those with exposure to blood and blood
products, those on maintaining hemodialysis, and those with
intravenous drug using [4]. Sexual contact and vertical route may
also mediate GBV-C transmission [5]. Due to shared transmission
modes, co-infection with GBV-C is common among people
infected with HIV-1 and/or HCV. Approximately, 10%–25% of
chronic hepatitis C patients and 14%–36% of Injecting Drug
Users (IDUs) seropositive for HIV-1 show the evidence of GBV-C
co-infection [6,7]. The much higher GBV-C triple infection rate of
30%–36% among individuals with HIV/HCV co-infection has
been reported by recent investigations [8,9].
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with 11–14% of nucleotide difference in the polyprotein coding
region between genotypes [10]. Currently, GBV-C has been
classified into six genotypes and many subtypes based on their
sequence diversity of either full genome length or a particular
genomic range. Geographically, these genotypes and subtypes
showed distinct distribution patterns. In general, genotype 1 is
predominant in African and is divided into five subtypes [11].
Genotype 2 has three subtypes [12] and is found in Europe and
America. Genotype 3 is the most common in Asia including Japan
and China. In contrast, genotype 4 is predominant in Southeast
Asia, and genotype 5 is only seen in South Africa. Recently,
genotype 6 is proposed with its sequences discovered in Indonesia
[10].
Although GBV-C infection has not been found in association
with any particular disease, its co-infection with HIV-1 may
produce some favorable outcomes, with a lower mortality rate,
slower disease progression, and longer survival term [13,14]. In
addition, GBV-C genotypes 2 and 5 have been found in connection
with a more delayed AIDS progression [10,15,16]. Recent studies
further show that HIV-1 infection and its downstream viral
replication can be inhibited by GBV-C E2 fusion peptide [17].
The mutation of a functional fragment (269–286 GTEVSEALG-
GAGLTGGFY), which specifically binds to HIV-1 gp41, may
impede this action [18]. Collectively, these findings suggest that
GBV-C genetic diversity has impacts on HIV-1 replication and
therefore, there is a need to study its genetic diversity in the context
of co-infection with other blood-borne viruses.
The Yunnan province is situated in southwest China. It
borders Southeast Asia countries of Laos, Vietnam and
Myanmar to the south. As a hub on the trans-continental drug
trafficking road, Yunnan has played a critical role in spreading
many blood-borne infections in China [19]. For example, HIV-1
is introduced from the Golden Triangle to Yunnan and then
spread to other provinces of the country [20]. It has been
considered that the recombinantion of current predominant
HIV-1 CRF_07 &_08 in China occurrs in Yunnan, as the origin
of their national wide prevalence [21,22]. For HCV, the unique
HCV genotypes distribution and existence of two novel subtypes
have been also revealed among this population [23,24].
Moreover, in this region, the general population has been
demonstrated to be threated with the more frequent HIV-1
spreading from IDUs through sex transmission [25].The high
infection rates of HIV-1 and HCV among IDUs have been
reported [26,27]. Furthermore, the change of HIV-1 and HCV
epidemic in neighboring regions, such as Guangxi and Sichuan
provinces was found to be on-going under the impact of their
prevalence in Yunnan [28,29].
Some studies have revealed that GBV-C infection occurs among
IDUs in Southern China [30]. However, there are no reports on
the GBV-C genotypes distribution among IDUs with co-infection
with HIV-1and/or HCV. Thus, the major purpose of this study
was to determine the prevalence of GBV-C genotypes among
IDUs. In this report, GBV-C infection was tested among 120
IDUs who were recruited from five prefectures of Yunnan
province. Dual or triple infection with HIV-1 and HCV were
also studied. After characterization of 59UTR and nearly entire E2
region sequences, a novel GBV-C genotype was discovered and its
predominance among the IDUs was revealed. With sequencing
and subsequent analysis of three full-length genomes, this novel
GBV-C genotype was confirmed. Furthermore, the analysis on E2
amino acid sequences of GBV-C was performed to evaluate its
possible effect on co-infected HIV-1.
Results
GBV-C detection and its co-infection with HIV-1 and HCV
A total of 120 IDUs were recruited from six drug detoxification
centers in five prefectures of Yunnan province, China. Among these
prefectures three (Dehong, Honghe, Wenshan) border Myanmar
and Vietnam, while two (Kunming and Dali) are located at the
central part of the province (Figure 1). Of the 120 IDUs, 102 were
males and 18 females. Their ages ranged between 20 and 65 years
old, with an average of 33 years old (SD=6.78). After amplification
of 59UTR (378bp) using nested RT-PCR, GBV-C RNA was
detected in 43 IDUs (35.8%). In the sampled prefectures, the GBV-
C RNA positive rates among IDUs were 46.7% for Kunming,
39.1% for Honghe and 53.3% for Dehong. There were no
significant differences between these prefectures. However, their
GBV-C RNA positive rates were significant higher than those for
Dali (6.3%) and Wenshan (15.4%). Detection of GBV-C anti-E2
revealed a GBV-C seropositive rate of 25.83% (31 IDUs). Only two
cases with clinically confirmed AIDS were positive for both GBV-C
anti-E2 and GBV-C RNA. Furthermore, 70 (58.3%) and 103
(85.8%) of all the recruited IDUs were detected to be sero-positive
for HIV-1 and HCV, respectively. Of them, 61 were sero-positive
for both HIV-1 and HCV (Table S1). These mono or double
infection rates ofHIV-1andHCVwere consistent with theprevious
reports [27]. Among the 43 IDUs positive for GBV-C RNA, nine
(7.5%) were co-infected withHIV-1,12 (10%) were co-infected with
HCV, and 22 (18.3%) co-infected with both HIV-1 and HCV
(Figure S1). Chi-square test showed that the rate of GBV-C/HIV-
1/HCV triple infection was significantly higher than those of GBV-
C/HIV-1 and GBV-C/HCV dual-infections (P,0.05).
GBV-C genotypes distribution and genotype 7
identification
The amplification of GBV-C 59UTR was successful for 43 IDUs
and the expected amplicons corresponded to nucleotides -414 to -
37 of the prototype GBV-C genome (U36380). Based on the
59UTR sequences, a phylogenetic tree was reconstructed. The tree
showed that the obtained 59UTR sequences were divided into
three phylogenetic groups. A sequence (2.3%) from Kunming
(KM07) was classified into genotype 3, the reported predominant
genotype in China. Two sequences (4.7%) from Dehong (DH019
and DH021) were classified into genotype 4, which was common
in Southeast Asia. Unexpectedly, the remaining 40 sequences
(93%) formed a solid cluster with a 97% of bootstrap support. This
cluster was distinct from the known six GBV-C genotypes,
suggesting the existence of a new genotype (Figure 2). For a
better illustration, the nearly entire E2 region sequence of GBV-C
was amplified from 25 IDUs. The amplicons were 1004 nt in
length and corresponded to nt 610-1613 of the U36380 genome.
The E2 region’s amplification of remaining 18 samples was failed,
probably due to low viral load, which is difficult to amplify the
long RNA fragment. Phylogenetic tree based on these E2 region
sequences showed grouping result consistent with that analyzed
with GBV-C 59UTR. These sequences were tightly clustered into
a novel group that has a bootstrap support of 99% (Figure 3). For
further verification, three full-length GBV-C genomes (KY117,
DL185, and DH028) were characterized. This was done using the
strategy shown in Figure S2 with each genome amplified by 13
overlapping fragments. To identify the position of the root of a
phylogenetic tree, the nucleotide sequence of the GBV-C
chimpanzee variant, GBV-Ctro was included as the out-group.
In this rooted phylogenetic tree (Figure. 4), the three full-length
GBV-C sequences formed a solid cluster. This cluster was distinct
from the known six GBV-C genotypes and had a 99% of bootstrap
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one leading to the KY117 and DL185 isolates and the other
leading to DH028. As a whole, this cluster was linked by a long
internal branch, which very similar to the forming of GBV-C
genotypes 4 and 6. To exclude the potential recent events of viral
recombination, similarity plotting was performed. Comparing the
three full-length GBV-C genome sequences with a series of
references, representing the known six GBV-C genotypes, no
meaningful finding was obtained (figures not shown). These results
may support a designation of the three full-length sequences as a
new GBV-C genotype we temporarily assigned genotype 7. Based
on the tree of partial and full-length genome sequences, genotype
4, 6 and the newly designated genotype 7 could be reclassified as
one group, which may represent a single GBV-C genotype, as
more GBV-C variants are characterized. The classification of
other four groups was corresponding to that of previous reported
genotype 1, 2, 3 and 5. The genotype 2/3 recombinant
(AB013501) and genotype 1/2/3 recombinant (U75356) were
belonged to genotype 2 and 3 groups respectively. It accounts to
the five groups or genotypes could be suggested in the modified
nomenclature system.
The three full-length GBV-C sequences, KY117, DL185, and
DH028, were further characterized. They all had a 389 nt of
59UTR, followed by a single ORF of 8529 nt and a 316 nt of
39UTR. They shared common sizes in seven protein-encoding
regions: E1(608 nt/212 aa), E2(1161 nt/387 aa), NS2(843 nt/281
aa), NS3(2031 nt/677 aa), NS4(945 nt/315 aa), NS5A(1245 nt/
415 aa), and NS5B(1692 nt/564 aa). Against six reference
sequences representing six known GBV-C genotypes, nucleotide
similarities were calculated (Table 1). Among the three genomes,
KY117, DL185, and DH028, the nucleotide similarities ranged
from 91.2 to 99.2% (mean 95.2%) over the complete genome
length and from 91.0 to 99.2% (mean 95.1%) over the entire ORF
range. Comparing KY117, DL185, and DH028 with the six
references, the nucleotide similarities were of 86.2 to 89.0% (mean
87.6%) over the complete genome length and of 86.1 to 88.8%
(mean 87.4%) over the entire ORF. Of the 7 protein-encoding
regions, NS5A (90.2%) and NS5B (88.9%) were the most
conserved, while E2 (mean 86.4%) and NS4 (mean 86.3%) the
highest variable. Inter-genotype similarity of GBV-C genotype 4
(mean 88.9%) and 6 (mean 88.8%) were higher than those of
genotype 1 (mean 86.3%) and 2 (mean 86.7%).
Co-analysis of reference GBV-C 59UTR sequences
Among the detected 43 GBV-C isolates, genotype 7 was the
most frequent accounting for 93%. In contrast, only one and two
isolates belonged to genotype 3 and 4, respectively, accounting for
2.3% and 4.7%. This GBV-C genotypes distribution pattern is
vastly different from those previously reported from China, in
which genotype 3 was most predominant [31,32]. This pattern
looks also different from that in Southeast Asia where GBV-C
genotypes 4 and 6 were common [10]. Regardless, the 43 GBV-C
Figure 1. Map of the Yunnan Province in the People’s Republic of China. Gray areas mark the five prefectures the 120 IDUs were recruited.
GBV-C positive rates were shown in percentages.
doi:10.1371/journal.pone.0021151.g001
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Southeast Asia. To verify this incongruity, a further analysis was
performed with 187 nt 59UTR sequences, corresponding to nt
-398 to -202 of the U36380 genome. Three references are
included for this co-analysis. Among them A94061 and K6
(HGU91716 and HGU91721) were unassigned isolates from
Thailand. IndHD92 was from a hepatitis patient in Indonesia, and
it had been previously grouped into GBV-C genotype 4 [33]. With
an 81% of bootstrap support, the three references were grouped
with KY117, DL185, and DH028 that were completely sequenced
in this study and assigned into genotype 7 (Figure 5). This analysis
supplies a piece of evidence that GBV-C genotype 7 is also
circulating in Southeast Asia.
Analysis of amino acid sequences of E2 region
It has been confirmed that certain E2 domains of GBV-C may
interfere with HIV-1 cellular entry by interaction with fusion
peptide-Vesicle [17,34,35]. These domains are considered as the
potential candidate for AIDS treatment and prevention. In this
study, a mathematical measure of entropy was performed to
evaluate the diversity of amino acids within a partial E2 region,
corresponding to 75 to 348 of the GBV-C E2 poly-protein
(Figure 6). This partial E2 region contains three relevant domains
(E2133–156,E 2 289–306 and E2325–342), which have been proved to
inhibit HIV entrance into target cell [36]. A total of 157 GBV-C
sequences belonging to seven GBV-C genotypes respectively, were
collected for analysis. Our data revealed 22 sites of analyzed
sequences had significant mutation (the entropy scores .0.4).
Among these sites, four mutation sites locate in the E2133–156
region, only one in E2289–306 region, and no one in E2325–342
region. The more mutation sites of E2133–156 may confer its impact
on the interaction of GBV-C and HIV-1. In alignment, the
consensus amino acid sequence (U45966) has been recently
demonstrated to block HIV-1 entry by interference with gp41-
Figure 2. Phylogenetic tree based on 59UTR sequences of 378 nt in length. The sequences corresponding to nucleotide positions -210 to
148 in the genome of prototype GBV-C isolate U36380. The known six GBV-C genotypes are indicated with number 1–6. Reference GBV-C sequences
is indicated with isolate names followed by their Genbank accession numbers. The neighbor-joining tree was constructed using the Jukes-Cantor
distances. Bootstrap values are shown in bold.
doi:10.1371/journal.pone.0021151.g002
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the amino acid sequence of our discovered genotype 7 was totally
consistent with that of the reported HIV-1 infection inhibitory
peptide. The results suggest that the co-infection of GBV-C
genotype 7 may depress the replication of HIV-1 and further delay
AIDS disease progression.
Discussion
In this study, the infection with HIV-1, HCV and GBV-C was
investigatedamong 120 IDUs whowere recruitedinfiveprefectures
of Yunnan province, China. We found the overall GBV-C RNA
positive rate (43/120, 35.8%) was agreed with previous reports that
GBV-C infection rate among IDUs ranged from 17.9% to 58.0%
[30,37,38]. Among the total recruited subjects, 70 (58.3%) and 103
(85.8%) were found to be anti-HIV and anti-HCV positive,
respectively. This accounted for 18.3% of IDUs having the GBV-
C/HIV-1/HCV triple infection, 7.5% and 10.0% IDUs having the
GBV-C/HIV-1 and GBV-C/HCV dual infection. Significantly,
the rate of GBV-C/HIV-1/HCV triple infection was higher
(P,0.05) than the rates of GBV-C/HIV-1 and GBV-C/HCV
dual infection. Notably, no one was detected to be GBV-C mono-
infection. It seems that the transmission of GBV-C though unsafe
syringe using is not effective as HCV or HIV-1. In addition, a
question is raised – if individuals with HIV-1/HCV dual infection
are more susceptible to opportunistic infection such as with GBV-C
[39]? Yet,an explicitanswerto this question requires more analyses.
Detection of GBV-C anti-E2 may be only indicative but not
conclusive, because it indicates either a past or an active GBV-C
infection depending on individuals. In this study, the majority of
anti-E2 positive IDUs (29/31) were RNA negative, for whom past
GBV-C infection was suggested [40]. However, in two IDUs who
were clinically confirmed to have AIDS, both GBV-C anti-E2 and
GBV-C RNA were positive, for whom active GBV-C infection was
approved. Since these two patients were also positive for anti-HIV,
Figure 3. Phylogenetic tree reconstructed with GBV-C E2 region sequences. These sequences were each 1004 bp in length, corresponding
to nt 610–1613 in the U36380 genome. Otherwise all the labels are as the same as shown in figure 2.
doi:10.1371/journal.pone.0021151.g003
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PLoS ONE | www.plosone.org 5 October 2011 | Volume 6 | Issue 10 | e21151Figure 4. Rooted phylogenetic tree based on the full-length GBV-C genome sequences of 48 isolates. The isolate GBV-C tro (Genbank
accession no. AF070476) was used as an outgroup. The symbol//indicates a trimmed branch. Putative recombinant isolates are boxed with dashed
lines. Otherwise all the labels are as the same as shown in figure 2.
doi:10.1371/journal.pone.0021151.g004
Table 1. Nucleotide similarities (%) of three genotype 7 isolations to 6 reference sequences in different genomic regions.
Compared
a Genome
b ORF 59UTR E1 E2 NS2 NS3 NS4 NS5A NS5B 39UTR
1(HGU36380) 86.5-86.9 86.4-86.8 87.2-87.7 85.4-87.0 84.9-86.3 84.2-85.3 85.1-85.4 85.8-86.1 89.2-89.8 88.3-88.6 95.9-96.8
2(HGU44402) 86.2-86.4 86.1-86.3 88.7-89.5 84.9-85.5 84.0-84.2 84.9-85.2 85.7-86.4 83.7-84.6 88.1-89.3 87.4-88.6 96.5-97.5
3/GT230(D90601) 87.6-88.3 87.5-88.2 89.5-90.0 86.8-87.7 85.6-87.0 87.7-88.5 86.1-86.7 87.2-88.8 89.4-89.7 89.3-90.2 96.5-97.5
4/MY14(AB018667) 88.8-89.0 88.6-88.8 91.8-93.6 87.7-89.3 88.1-88.7 87.0-87.4 86.7-87.6 87.9-88.7 92.0-92.3 88.7-90.3 96.2-97.1
5/D50(AY949771) 86.9-87.3 86.9-87.2 87.2-88.7 87.3-87.7 84.2-85.0 84.1-86.4 84.2-85.4 86.8-88.3 89.8-91.0 89.2-90.0 ,
c
6/G05BD(AB003292) 88.6-88.8 88.5-88.7 90.0-91.6 88.5-91.0 88.5-88.8 89.1-89.3 85.7-86.2 88.5-88.8 90.8-90.9 89.0-89.8 ,
c
KY117 vs DL185 99.2 99.2 98.9 99.8 99.2 99.2 99.5 98.6 99.2 99.1 99.7
KY117 vs DH028 91.2 91.1 94.9 92.9 91.5 90.7 89.9 89.0 92.9 91.5 98.7
DL185 vs DH028 91.2 91.0 95.4 93.1 91.1 90.3 89.7 89.1 92.9 91.8 99.0
aIsolates to which the three genotype 7 sequences were pairwise compared. Each genotype was represented by one isolate as indicated with its Genbank accession
number shown in parenthesis.
bOver the entire genome length.
cD50 and G05BD lack the 3’UTR.
doi:10.1371/journal.pone.0021151.t001
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markers, anti-HIV, GBV-C anti-E2, and GBV-C RNA, may reflect
the fact that these individuals have more serious immunity damage;
they may have produced higher titer of virus.
For GBV-C genotyping, different methods have been used.
These included RT-PCR with specific primers, restriction
fragment length polymorphism, and direct DNA sequencing
[41]. Among these methods, DNA sequencing is the gold standard
and the most preferred but requires phylogenetically informative
regions to be analyzed. For such a purpose, the highly conserved
59-UTR or its partial fragment is often concerned [10]. Some
researchers have argued that phylogenetic analysis of this region
may not always supply a solid genotyping result. In contrast,
sequencing the complete or partial E2 region can provide stronger
information, which is nearly in a complete accordance with
sequencing the full-length GBV-C genomes [42]. Ultimately,
defining a new viral variant or assigning a novel viral group
constantly requires the full-length viral genome(s) being charac-
terized. Based on this premise, a stepwise strategy was used in this
study to process samples collected from 120 IDUs. Firstly,
sequence of GBV-C 59UTR was screened for all samples and
this resulted in 43 samples (35.8%) positive. Of the obtained 43
isolates, 40 (93%) were classified into a new phylogenetic group.
Secondly, the complete GBV-C E2 region was amplified in
samples positive for GBV-C 59UTR. This was done to verify the
new GBV-C group. From 24 IDUs the E2 region sequences were
amplifiable and all were classified into a new GBV-C group we
provisionally designated GBV-C genotype 7. Lastly, three full-
length GBV-C genomes were characterized; it provides us the
ultimate information for defining a new genotype.
Of this study, the GBV-C genotype distribution pattern is vastly
different from that previously reported inChina wheregenotype3 is
predominant [23,24]. This pattern looks also different from that
observed in Southeast Asia where genotypes 4 and 6 are common
[10]. Co-analysis of reference 59UTR sequences showed that GBV-
C genotype 7 was also found in Southeast Asia, albeit not common.
The basal location of Southeast Asia sequences in phylogenetic tree
implies that GBV-C genotype 7 may be indigenous in this region.
Recently, an overland drug trafficking route may have exchanged
viral strains with those in Southeast Asia. Through Yunnan as a
center, this route has been proven to play a critical role in the
transmission of HIV-1 and HCV infection from Southeast Asia to
the other parts China [43,44]. Mutually, this route may have also
spread the infection with GBV-C between Yunnan and its
neighboring countries. Up to now, GBV-C genotype 7 has not
been found in other provinces marginal to Yunnan, such as
Guangxi and Sichuan, where genotype 3 was the only discovered
GBV-C strains major due to the lake of recent GBV-C investigation
Figure 5. Phylogenetic tree based on partial 59UTR region sequences. These sequences were each 187 nt in length, corresponding to
nucleotides -398,-202 in the genome of GBV-C isolate U36380. The tree was constructed using the Minimum Evolution method. Except for G7, all
the isolates were adopted from the previous report by Muerhoff et al. [2006].
doi:10.1371/journal.pone.0021151.g005
Identification & Predominance of GBV-C Genotype 7
PLoS ONE | www.plosone.org 7 October 2011 | Volume 6 | Issue 10 | e21151there. However, the spread of this novel GBV-C genotype through
modern transmission route could be predicted.
In this study, GBV-C genotype 7 was designated by following the
system Mueroff and his colleagues had recommended [10,45].
However, based on the analysis of E2 region sequences and/or full-
length genomes, five major GBV-C groups may be proposed. Four
groups are represented by genotypes 1, 2, 3 and 5, respectively; while
the fifth group is composed of genotypes 4, 6 and the newly designated
GBV-C genotype 7. For more than a decade, GBV-C had been well
classified into four genotypes: 1–4. This has been established with
sequences having origins from exclusive geographic regions: genotype
1 from Africa, genotype 2 from Europe and America, genotype 3 from
East Asia, and genotype 4 from Southeast Asia. Recently, genotype 5
has been proposed with sequences from Africa [45]. Genotype 6 has
been separated from genotype 4 with sequences from Indonesia and
Japan [10]. Using a similar approach, we also separated an Indonesian
isolate, IndHD92, from a previous grouping into genotype 4 as a now
grouping into genotype 7 (Figure 3). Genotypes 4, 6, and 7 can
compose a larger genetic group (Figure 2), which geographically from
Southeast Asia or its neighboring region such as Yunnan in the present
study. These distribution patterns indicate their common origins.
Unlike many other viruses, currently there is a lack of consented and
quantified criteria set for GBV-C classification of nucleotide sequences.
Even though such a standard is established, it may not always meet the
increasing need of classifying new viral variants. For example, new
variants are kept being identified for HCV. However, a previously
quantified criterion failed to classify them consistently, which had
caused a confusion of six or 11 HCV genotypes. For this reason, a
consensuspaperhasbeensubsequentlymodified,whichnow uniformly
classifies HCV isolates based on phylogenetic analyses of their genetic
sequences, no matter how greater genetic distances may be obtained
[46]. This wisdom should be also applied for GBV-C classification, we
strongly recommend. Following this scheme, all GBV-C isolates would
be classified into five major groups to assist for a simpler GBV-C
nomenclature. On the other hand, virus genetic variation is a reflection
of the continuous mutations accumulated over the past history of viral
evolution. Spatial niches with variants of different evolutionary extents
do exist. However, due to limited sampling and technical restriction,
many of such variants have not been identified. These variants may
present continuous genetic variations to fill the gaps between GBV-C
genotypes 4, 6, and 7, we strongly believe. As more such variants are
characterized, a simpler GBV-C nomenclature may be modified.
A benefit of GBV-C infection on disease progression of AIDS or
HIV-1 replication has been documented [18]. However, the
Figure 6. Analysis on amino acid sequences of E2 region. The entropy score (a mathematical measure of variability) at amino acid positions
75-348 within E2 region, analyzed with 158 GBV-C isolates. The gray bar indicates the amino acid positions starting from 75 and ending at 348. Within
the gray bar a blue area indicates the three putative GBV-C E2 peptides inhibited HIV infection corresponding to aa 133–156, 289–306 and 325–342.
Five red and 18 blue dots linking under the gray bar represent the 23 positions having the entropy score $0.4 (regarded as high variability) hat is
measure by the scale on the left. A curve under the gray bar plots the entropy score against each amino acid position that is numbered by the ruler at
the bottom. The blue area of the gray bar is further expanded; it shows an alignment of the consensus amino acid sequences from seven GBV-C
genotypes spanning the blue area. In the alignment, the reported HIV-1 entry blocking peptide domain of GBV-C E2 region are cited as the consensus
sequence. Symbol * indicates the site with variation lower than 10%, which considered as conservation site. For comparison, 21 reference strains of
genotype 1, 64 strains of genotype 2, 26 strains of genotype 3, 2 strains of genotype 4, 18 strains of genotype 5, 2 strains of genotype 6 and 25 strains
of our discoved genotype 7 were apopted. The pink little tri-angle, diamond and disk represent the mutation in this site account for 10%-20%, 20-
50% and more than 50% of total cited strains in this genotype, respectively.
doi:10.1371/journal.pone.0021151.g006
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related diseases remains to be investigated. Although a few reports
have described that GBV-C genotype 2 (2a and 2b) and 5 may be
in association with a better immunological response among
patients co-infected with HIV-1 [12,16], there is a still lack of
evidence supporting that GBV-C genetic diversity affects the HIV-
1 caused clinical presentation. The identification of GBV-C
genotype 7 and its predominance among IDUs enhanced our
curiosity: if there is a correlation between GBV-C genotypes and
the presence of clinical AIDS markers, which include CD4
+ cell
count and HIV-1 viral load. In addition, there is a need of
investigating the correlation between GBV-C genotypes and HIV-
1 subtypes or circulating recombinant forms (CRFs). As cousins of
Flaviviridea, GBV-C and HCV have similar genome organization.
A potential association between the two viruses in the context of
genetic diversity and evolution also need to be investigated.
Materials and Methods
Subjects and specimens
A total of 120 IDUs were recruited, from whom anti-coagulated
blood samples were collected. These IDUs were retained in six drug
detoxification centers in five prefectures of the Yunnan province,
China, during 2005–2008. Among them, 30 were from Kunming,
46 from Honghe, 13 from Wenshan, 15 from Dehong, and 16 from
Dali (Table S1). This study and the consent procedure were
approved by the local ethical review committee at the Yunnan
Center for Disease Control and the Kunming University of Science
and Technology. Verbal consent was obtained from recruited
IDUs. Written consent was not necessary because no personal
information, which may impact the life and reputation of attender,
was recorded. The personal information was not included in
publication. Serum anti-HCV, anti-HIV-1, and anti-E2 of GBV-C
weretestedusingenzymeimmunoassays(ELISA;KehuaCompany,
Shanghai, China; GBV-C/HGV env kit, Roche Diagnostics,
Sydney, Australia). Samples positive for anti-HIV-1 were further
confirmed using Western blot assay (BioRad, Singapore).
Detection of GBV-C 59UTR and E2 region sequences
Viral RNA was extracted from 200 ml plasma using High Pure
Viral RNA Kit (Roche Applied Science). This was followed by RT-
nested-PCR using the primers listed in Table S2 that targeted the
GBV-C 59UTR and E2 region. The first round RT-PCR was
performed with 4 pmol of each outer primer using the AMV RNA
PCR Kit (TaKaRa, Ver. 3.0). The second round PCR was conducted
with 4pmol of each inner primer using the Premix Taq Kit (TaKaRa,
EXTaqTM Ver). The samples with visible bands of predicted size
were considered positive for GBV-C and the DNA was recovered.
Amplification of the full-length GBV-C genome
From three GBV-C RNA + samples, full-length GBV-C genomes
were characterized. To amplify the GBV-C complete genome, 51
primers were designed based on the aligned reference sequences. Their
sequences were listed in Table S2 and the strategy was shown in Figure
S2, generating 13 overlapping fragments for each isolate.
Sequencing and phylogenetic analysis
All the amplicons were directly sequenced, and sequence
information was analyzed using the BLAST, CLUSTAL_W,
BioEdit and Mega 4 software. In more detail, the obtained
sequences were confirmed as GBV-C using the NCBI (National
Center for Biotechnology Information) BLAST searching program
(http://www.ncbi.nlm.nih.gov) and aligned with reference se-
quences using CLUSTAL_W program. Further adjustments to the
alignments were manually made using BioEdit program. Bootstrap
resampling was performed with 1000 neighbour-joining replicates.
Phylogenetic analysis of 59UTR, E2 region, and full-length
sequences was conducted using Mega 4 software, which employed
Jukes-Cantor distances of neighbour-joining tree.
Nucleotide sequence accession numbers
The sequences reported in this paper have been deposited in
GenBank with the following accession numbers: HQ331171 to
HQ331235.
Supporting Information
Figure S1 GBV-C, HCV and HIV-1 mono, dual or triple
infection rates. The symbol ** indicates the rate of GBV-C/
HIV-1/HCV triple infection was significantly higher than that of
GBV-C/HIV-1 and GBV-C/HCV dual infection.
(TIF)
Figure S2 Strategies used to amplify the KY117, DL185
and DH028 complete genomes. The bar at top represents the
genomic organization of GBV-C and shows the seven protein
encoding regions of various lengths, flanked by the 59 and 39
UTRs. Nucleotide numbering is according to the U36380
genome. Arrows represent the overlapping fragments amplified
for the three GBV-C isolates.
(TIF)
Table S1 The infection rates of GBV-C/HCV/HIV-1
among recruited IDUs in Yunnan province.
(DOC)
Table S2 Primers used for amplification and sequenc-
ing of the GBV-C genome.
(DOC)
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